REVERSIBLE LEUKOPENIA RELATED TO CIPROFLOXACIN THERAPY

[1] ARCIERI G, 1987, AM J MED, V82, P381

[2] CIPROFLOXACIN - AN OVERVIEW OF ADVERSE EXPERIENCES [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 : 187 - 193

[3] CIPROFLOXACIN THERAPY OF INFECTIONS CAUSED BY PSEUDOMONAS-AERUGINOSA AND OTHER RESISTANT-BACTERIA [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) : 308 - 310

[4] Halkin H, 1988, Rev Infect Dis, V10 Suppl 1, pS258

[5] HESSEN MT, 1987, AM J MED, V82, P262

[6] THE FLUOROQUINOLONES - PHARMACOLOGY, CLINICAL USES, AND TOXICITIES IN HUMANS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) : 716 - 721

[1] ARCIERI G, 1987, AM J MED, V82, P381

[2] CIPROFLOXACIN - AN OVERVIEW OF ADVERSE EXPERIENCES [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 : 187 - 193

[3] CIPROFLOXACIN THERAPY OF INFECTIONS CAUSED BY PSEUDOMONAS-AERUGINOSA AND OTHER RESISTANT-BACTERIA [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) : 308 - 310

[4] Halkin H, 1988, Rev Infect Dis, V10 Suppl 1, pS258

[5] HESSEN MT, 1987, AM J MED, V82, P262

[6] THE FLUOROQUINOLONES - PHARMACOLOGY, CLINICAL USES, AND TOXICITIES IN HUMANS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) : 716 - 721